➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Medtronic
Dow
Baxter
Merck

Last Updated: May 13, 2021

DrugPatentWatch Database Preview

Glenmark Pharms Ltd Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for GLENMARK PHARMS LTD, and what generic and branded alternatives to GLENMARK PHARMS LTD drugs are available?

GLENMARK PHARMS LTD has sixty-nine approved drugs.

There are seven tentative approvals on GLENMARK PHARMS LTD drugs.

Summary for Glenmark Pharms Ltd
US Patents:0
Tradenames:58
Ingredients:55
NDAs:69

Drugs and US Patents for Glenmark Pharms Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Pharms Ltd LIDOCAINE lidocaine OINTMENT;TOPICAL 206498-001 Sep 9, 2016 AT RX No No   Get Started for $10   Get Started for $10
Glenmark Pharms Ltd CHLORPROMAZINE HYDROCHLORIDE chlorpromazine hydrochloride TABLET;ORAL 212144-005 Mar 23, 2021 AB RX No No   Get Started for $10   Get Started for $10
Glenmark Pharms Ltd CLOBETASOL PROPIONATE clobetasol propionate SOLUTION;TOPICAL 210190-001 Apr 18, 2018 AT RX No No   Get Started for $10   Get Started for $10
Glenmark Pharms Ltd TELMISARTAN telmisartan TABLET;ORAL 090032-001 Jul 7, 2014 AB RX No No   Get Started for $10   Get Started for $10
Glenmark Pharms Ltd DIMETHYL FUMARATE dimethyl fumarate CAPSULE, DELAYED RELEASE;ORAL 210309-001 Oct 6, 2020 AB RX No No   Get Started for $10   Get Started for $10
Glenmark Pharms Ltd SIROLIMUS sirolimus TABLET;ORAL 208691-002 Oct 16, 2020 AB RX No No   Get Started for $10   Get Started for $10
Glenmark Pharms Ltd HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 090527-004 May 27, 2009 AA RX No No   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
McKinsey
AstraZeneca
Medtronic
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.